seri
thiazol
club
deriv
synthes
character
ir
h
nmr
c
nmr
mass
spectral
analysi
synthes
compound
evalu
antimicrobi
cytotox
activ
result
indic
compound
exhibit
potent
antibacteri
activ
compound
found
potent
antifung
agent
structur
activ
relationship
reveal
presenc
electron
withdraw
group
para
posit
phenyl
ring
remark
enhanc
antibacteri
activ
synthes
compound
result
preliminari
mtt
cytotox
studi
hela
cell
suggest
potent
antimicrobi
activ
accompani
low
cytotox
treatment
infecti
diseas
still
remain
challeng
task
combin
factor
alarm
increas
number
multidrugresist
microbi
pathogen
advent
newer
infecti
diseas
sever
acut
respiratori
syndrom
sar
avian
influenza
despit
avail
larg
number
antibiot
chemotherapeut
increas
clinic
import
drugresist
microbi
pathogen
lent
addit
urgenc
microbiolog
antifung
research
potenti
solut
antibiot
resist
design
explor
innov
heterocycl
agent
novel
mode
action
context
thiazol
deriv
play
crucial
role
medicin
chemistri
thiazol
nucleu
constitut
integr
part
avail
penicillin
transform
bacteri
diseas
therapi
display
quit
broad
spectrum
biolog
activ
found
applic
treatment
allergi
hypertens
inflamm
schizophrenia
microbi
infect
hiv
infect
hypnot
pain
also
use
new
inhibitor
bacteri
dna
gyras
b
thiazol
emerg
new
class
potent
antimicrobi
agent
report
inhibit
bacteria
block
biosynthesi
certain
bacteri
lipid
addit
mechan
hand
heterocycl
good
bioisoster
amid
ester
contribut
substanti
enhanc
pharmacolog
activ
particip
hydrogen
bond
interact
receptor
potent
pharmacolog
activ
attribut
presenc
toxophor
en
ceoe
linkag
may
react
nucleophil
center
microbi
cell
widespread
use
scaffold
medicin
chemistri
establish
moieti
member
privileg
structur
class
deriv
exhibit
wide
rang
biolog
activ
antibacteri
antitubercular
vasodialatori
antifung
cytotox
antiinflammatori
analges
hypolipidem
anticanc
ulcerogen
oxadiazol
deriv
found
possess
broad
spectrum
antimicrobi
activ
therefor
use
substructur
molecular
explor
promin
exampl
prescrib
agent
featur
nucleu
includ
antiretrovir
raltegravir
antihypertens
nesapidil
antibiot
furamizol
fig
prompt
abovement
observ
continu
search
new
potent
select
less
toxic
antimicrobi
agent
report
herein
synthesi
novel
structur
hybrid
combin
thiazol
pharmacophor
singl
molecular
framework
order
investig
vitro
antimicrobi
activ
addit
cytotox
studi
also
conduct
hela
cell
line
evalu
abil
compound
inhibit
cell
growth
substitut
pattern
ring
care
select
order
confer
differ
electron
environ
molecul
reaction
sequenc
employ
synthesi
target
compound
outlin
scheme
ethyl
taken
start
materi
react
acet
anhydrid
afford
ethyl
reaction
hydrazin
hydrat
absolut
ethanol
yield
intermedi
n
hydrazin
carbonyl
acetamid
intermedi
obtain
thu
reflux
carbon
disulfid
presenc
potassium
hydroxid
ethanol
yield
intermedi
n
acetamid
mannich
condens
intermedi
formaldehyd
appropri
substitut
anilin
deriv
ethanol
furnish
desir
compound
analyt
spectral
data
synthes
compound
fulli
agreement
propos
structur
format
titl
compound
confirm
characterist
ir
spectrum
absorpt
band
rang
cm
cm
cm
cm
cm
correspond
enh
stretch
secondari
amin
enh
stretch
amid
ech
ech
e
c
amid
respect
singlet
around
ppm
h
nmr
due
e
ch
anilid
group
hetech
secondari
amin
ech
e
enh
amid
group
respect
aromat
ring
proton
observ
ppm
j
valu
found
accord
substitut
pattern
phenyl
ring
characterist
peak
around
ppm
c
nmr
confirm
presenc
c
c
group
respect
mass
spectrum
reveal
observ
molecular
ion
peak
agreement
molecular
weight
respect
compound
synthes
compound
evalu
vitro
antibacteri
activ
staphylococcu
aureu
mtcc
streptococcu
pyogen
mtcc
gramposit
escherichia
coli
mtcc
pseudomona
aeruginosa
mtcc
gramneg
convent
broth
microdilut
method
use
chloramphenicol
control
drug
antibacteri
activ
result
antimicrobi
studi
present
tabl
gener
compound
demonstr
better
antibacteri
activ
antifung
activ
compound
emerg
effect
antibacteri
agent
higher
mic
mgml
refer
drug
chloramphenicol
compound
exhibit
compar
antibacteri
activ
standard
drug
result
antimicrobi
activ
synthes
compound
follow
structur
activ
relationship
deriv
antibacteri
activ
consider
affect
substitut
pattern
phenyl
ring
activ
compound
contain
electron
withdraw
substitu
para
meta
posit
phenyl
ring
p
contrast
presenc
electron
releas
group
phenyl
ring
wit
substanti
decreas
antibacteri
activ
compound
role
electron
withdraw
group
improv
antimicrobi
activ
well
support
previou
studi
compound
substitut
induct
electron
withdraw
fluoro
nitro
group
respect
para
posit
show
highest
antibacteri
activ
f
wellknown
fact
electron
withdraw
substitut
fluoronitro
para
posit
aromat
ring
increas
lipophil
molecul
properti
directli
relat
antimicrobi
activ
facilit
compound
diffus
biolog
membran
reach
site
action
presenc
lipophil
substitu
para
posit
phenyl
ring
provid
posit
influenc
antibacteri
activ
hand
presenc
function
group
meta
posit
result
slight
decreas
antibacteri
activ
still
produc
signific
inhibitori
action
compar
standard
drug
chloramphenicol
f
substitut
phenyl
ring
fluoro
nitro
group
ortho
posit
result
notic
decreas
antibacteri
activ
compound
respect
basi
mic
valu
may
conclud
electron
withdraw
atomgroup
fluoro
nitro
para
posit
phenyl
ring
induc
posit
effect
electron
donat
group
methyl
methoxi
induc
neg
effect
antibacteri
activ
compound
vitro
antifung
activ
synthes
compound
determin
candida
albican
mtcc
aspergillu
niger
mtcc
aspergillu
clavatu
mtcc
convent
broth
microdilut
method
result
indic
compound
substitut
methoxi
group
para
posit
phenyl
ring
found
promis
agent
c
albican
niger
higher
mic
mgml
comparison
control
drug
ketoconazol
enhanc
activ
compound
may
attribut
presenc
electron
releas
group
para
posit
contrast
natur
substitut
pattern
para
posit
phenyl
ring
activ
antibacteri
antifung
agent
indic
structur
requir
differ
bind
drug
bacteri
fungal
target
respect
compound
show
less
inhibit
test
microorgan
compar
standard
drug
vitro
cytotox
compound
evalu
human
cervic
cancer
cell
line
hela
bromid
mtt
colorimetr
assay
measur
reduct
tetrazolium
bromid
salt
formazan
dye
mitochondri
dehydrogenas
treat
versu
untreat
cell
result
summar
tabl
observ
none
test
compound
exhibit
signific
cytotox
effect
hela
cell
suggest
great
potenti
vivo
use
antimicrobi
agent
conclus
new
structur
hybrid
thiazol
synthes
investig
antimicrobi
properti
anticip
gener
new
structur
lead
serv
potent
antimicrobi
agent
mani
synthes
motif
possess
electron
withdraw
atomgroup
fluoro
nitro
para
meta
posit
identifi
potent
antibacteri
agent
albeit
observ
para
posit
favor
enhanc
antibacteri
activ
compound
electron
releas
group
para
posit
came
promis
antifung
agent
potent
antimicrobi
activ
activ
compound
accompani
rel
low
level
cytotox
result
describ
merit
investig
laboratori
use
forward
chemic
genet
approach
find
lead
molecul
antimicrobi
agent
reaction
except
aqueou
media
carri
standard
techniqu
exclus
moistur
melt
point
determin
electrotherm
melt
point
apparatu
report
uncorrect
tlc
silica
gel
plate
merck
f
use
puriti
check
reaction
monitor
column
chromatographi
silica
gel
merck
mesh
mesh
asth
flash
chromatographi
appli
necessari
isol
purifi
reaction
product
element
analysi
c
h
n
carri
perkineelm
chn
analyz
ir
spectra
compound
record
perkin
elmer
ftir
spectrophotomet
kbr
h
nmr
spectra
record
varian
gemini
mhz
c
nmr
spectra
varian
mhz
dmsod
solvent
tetramethylsilan
tm
intern
standard
mass
spectra
scan
shimadzu
lcm
spectromet
reaction
requir
anhydr
condit
carri
nitrogen
atmospher
use
ovendri
glasswar
ethyl
mol
taken
round
bottom
flask
acet
anhydrid
mol
ad
reaction
mixtur
reflux
c
h
pour
cold
water
constant
stir
get
solid
product
mixtur
heat
boil
decompos
excess
acet
anhydrid
cool
solid
obtain
filter
wash
water
dri
ethyl
acetyl
amino
collect
recrystal
ethanol
get
pure
white
crystal
yield
mp
c
anal
ob
c
h
n
calcd
c
h
n
c
h
n
intermedi
mol
hydrazin
hydrat
mol
taken
round
bottom
flask
mixtur
reflux
min
alcohol
ad
till
layer
miscibl
reflux
continu
h
excess
alcohol
unreact
hydrazin
hydrat
distil
content
pour
beaker
solid
recrystal
ethanol
get
pure
crystallin
product
dmso
use
diluent
get
desir
concentr
compound
test
upon
standard
bacteri
strain
serial
dilut
prepar
primari
secondari
screen
control
tube
contain
antibiot
immedi
subcultur
inocul
spread
loop
evenli
quarter
plate
medium
suitabl
growth
test
organ
put
incub
c
overnight
tube
incub
overnight
mic
control
organ
read
check
accuraci
compound
concentr
mic
defin
lowest
concentr
antibiot
test
sampl
allow
visibl
growth
tube
show
visibl
growth
control
tube
subcultur
incub
overnight
c
amount
growth
control
tube
incub
repres
origin
inoculum
compar
subcultur
might
show
similar
number
coloni
indic
bacteriostat
reduc
number
coloni
indic
partial
slow
bactericid
activ
growth
whole
inoculum
kill
test
must
includ
second
set
dilut
inocul
organ
known
sensit
synthes
compound
dilut
obtain
mgml
concentr
stock
solut
primari
screen
mgml
concentr
synthes
compound
taken
activ
synthes
compound
found
primari
screen
test
second
set
dilut
microorgan
compound
found
activ
primari
screen
similarli
dilut
obtain
mgml
concentr
highest
dilut
show
least
inhibit
taken
mic
vitro
cytotox
determin
use
standard
mtt
assay
protocol
appropri
individu
test
system
test
compound
prepar
prior
experi
dissolv
dmso
dilut
medium
cell
expos
differ
concentr
drug
mm
volum
mmwell
cell
control
well
receiv
volum
medium
contain
dmso
h
medium
remov
cell
cultur
incub
ml
mtt
reagent
mgml
h
c
suspens
place
micro
vibrat
min
absorb
record
elisa
reader
experi
perform
triplic
human
cancer
cell
line
hela
cell
cultur
mem
medium
supplement
fb
glutamin
mmml
gentamicin
sulphat
co
incub
humidifi
atmospher
co
air
